Drug: Bevacizumab Injury: Hypokalaemia Quarter: 2016Q3
Total Records: 43 Number of Pages: 3
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 126883782 | Bevacizumab | Hypokalaemia | ROCHE | 0.00 | 0 | 20160828 | CN | |
| 127138881 | Bevacizumab | Hypokalaemia | ROCHE | 51.00 YR | M | 70 KG | 20160905 | US |
| 127154622 | Bevacizumab | Hypokalaemia | ROCHE | 0.00 | 0 | 20160907 | US | |
| 127174031 | BEVACIZUMAB | Hypokalaemia | JANSSEN | 0.00 | F | 0 | 20160906 | US |
| 127335871 | Bevacizumab | Hypokalaemia | ROCHE | 0.00 | F | 0 | 20160912 | US |
| 127413111 | Bevacizumab | Hypokalaemia | ROCHE | 65.23 YR | M | 52 KG | 20160914 | US |
| 127446291 | Bevacizumab | Hypokalaemia | ROCHE | 21.00 YR | M | 55 KG | 20160915 | US |
| 127449201 | Bevacizumab | Hypokalaemia | ROCHE | 48.87 YR | F | 72 KG | 20160915 | US |
| 127450631 | Bevacizumab | Hypokalaemia | ROCHE | 61.00 YR | M | 66 KG | 20160915 | US |
| 127501091 | Bevacizumab | Hypokalaemia | ROCHE | 62.00 YR | F | 72 KG | 20160916 | US |
| 127540771 | Bevacizumab | Hypokalaemia | ROCHE | 52.00 YR | M | 90 KG | 20160916 | US |
| 127576561 | Bevacizumab | Hypokalaemia | ROCHE | 42.00 YR | F | 106 KG | 20160919 | US |
| 127825551 | Bevacizumab | Hypokalaemia | ROCHE | 69.00 YR | F | 86 KG | 20160927 | US |
| 127825681 | Bevacizumab | Hypokalaemia | ROCHE | 76.00 YR | F | 58 KG | 20160927 | US |
| 127905841 | Bevacizumab | Hypokalaemia | ROCHE | 56.00 YR | F | 69 KG | 20160929 | US |
| 127907991 | Bevacizumab | Hypokalaemia | ROCHE | 65.00 YR | F | 100 KG | 20160929 | US |
| 127911311 | Bevacizumab | Hypokalaemia | ROCHE | 0.00 | F | 63 KG | 20160929 | US |
| 127975001 | Bevacizumab | Hypokalaemia | ROCHE | 68.70 YR | F | 0 | 20160930 | US |
| 127975691 | Bevacizumab | Hypokalaemia | ROCHE | 75.04 YR | F | 71 KG | 20160930 | US |
| 127986121 | Bevacizumab | Hypokalaemia | ROCHE | 62.00 YR | F | 72 KG | 20160930 | US |
Total Records: 43 Number of Pages: 3